Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT01370512
PHASE2

Droxidopa / Pyridostigmine in Orthostatic Hypotension

Sponsor: Mayo Clinic

View on ClinicalTrials.gov

Summary

This study is being done to study the combination of pyridostigmine and low-dose Droxidopa for the treatment of orthostatic hypotension.

Official title: Treatment Trial of Droxidopa and Pyridostigmine to Improve Orthostatic Hypotension Without Aggravating Supine Hypertension

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2011-11

Completion Date

2026-05

Last Updated

2025-07-14

Healthy Volunteers

No

Interventions

DRUG

Droxidopa

100 mg tablets by mouth three times a day

DRUG

Pyridostigmine

60 mg tablets by mouth three times a day

OTHER

Placebo

Looks exactly like the study drug but contains no active ingredients

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States